Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

BEHAVIORAL(2)

DRUG(2)

MIXED(1)

Carfentanil

1 trial

phase_1

national-institute-on-drug-abuse-nida

Nicotine

1 trial

phase_1

national-institute-on-drug-abuse-nida

Neutral Cues

1 trial

not_applicable

university-of-maryland-baltimore

Smoking Cues

1 trial

not_applicable

university-of-maryland-baltimore

Varenicline

1 trial

phase_1

national-institute-on-drug-abuse-nida

5 unique interventions3 categories

Analytics

Trial Phases

Phase 12

Trial Status

Completed6

Other1

Role Distribution

Principal Investigator7

PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT00770237Not ApplicableCompleted

Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia

Nicotine DependenceSchizophrenia

PrincipalinvestigatorStart date: 2008-10-01

NCT00618631Phase 1Completed

Effects of Smoking on Opioid Receptor Binding: A PET Study

Substance-related Discorder

Principalinvestigator

NCT01031433Completed

Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality

Nicotine Dependence

Principalinvestigator

NCT01034384Completed

Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco Abstinence

Smoking Cessation

Principalinvestigator

NCT01212081Completed

Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality

Cannabis Use

Principalinvestigator

NCT01309685Phase 1Withdrawn

Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment

Drug Addiction

Principalinvestigator

NCT01505725Completed

Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms

Nicotine Dependence

Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Nicotine Dependence3 Cannabis Use1 Drug Dependence1 Schizophrenia1 Smoking Cessation1 Substance-related Discorder1

Affiliations

National Institute on Drug Abuse (NIDA)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Deanna L Kelly, Pharm.D, BCPP

University of Maryland, College Park

2 trials

Shared therapeutic areas:

Nicotine DependenceSchizophrenia

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)University of Maryland, Baltimore

Collaborated on 1 trial

Similarity Score24%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

20 trials

Shared therapeutic areas:

Nicotine DependenceSchizophreniaDrug Dependence+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)

Similarity Score20%

Jed E Rose, Ph.D.

Duke University

11 trials

Shared therapeutic areas:

Nicotine DependenceSmoking Cessation

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)

Similarity Score10%

Olivier Beauchet, MD

Jewish General Hospital

19 trials

Shared therapeutic areas:

Cannabis Use

Similarity Score5%

Sanjeev Pathak, MD

Alkermes, Inc.

13 trials

Shared therapeutic areas:

Schizophrenia

Similarity Score5%

emilie garrido pradalie

APHM

35 trials

Shared therapeutic areas:

Cannabis Use

Similarity Score5%

Mark George, MD

Medical University of South Carolina

6 trials

Shared therapeutic areas:

Smoking Cessation

Similarity Score5%

Madhukar Trivedi, MD

University of Texas Southwestern Medical Center

13 trials

Shared therapeutic areas:

Smoking Cessation

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)

Similarity Score5%

Jean-Olivier ARNAUD, Director

Assistance Publique Hôpitaux de Marseille

17 trials

Shared therapeutic areas:

Schizophrenia

Similarity Score5%

Mohamed AbdElmoniem

Lecturer of chest medicine faculty of medicine Mansoura university

13 trials

Shared therapeutic areas:

Smoking Cessation

Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT00770237Not ApplicablePrincipalInvestigator

Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia

Nicotine DependenceSchizophrenia

Completed

NCT00618631Phase 1PrincipalInvestigator

Effects of Smoking on Opioid Receptor Binding: A PET Study

Substance-related Discorder

Completed

NCT01031433PrincipalInvestigator

Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality

Nicotine Dependence

Completed

NCT01034384PrincipalInvestigator

Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco Abstinence

Smoking Cessation

Completed

NCT01212081PrincipalInvestigator

Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality

Cannabis Use

Completed

NCT01309685Phase 1PrincipalInvestigator

Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment

Drug Addiction

Withdrawn

NCT01505725PrincipalInvestigator

Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms

Nicotine Dependence

Completed

All 7 trials loaded